Global Needle Free Injection System Market Assessment, By Products [Fillable, Prefilled], By Technology [Spring Based Needle Free Injectors, Gas Powered Needle Free Injectors, Laser Powered Needle Free Injectors, Vibration Based Needle Free Injectors], By Site of Delivery [Intradermal, Intramuscular, Subcutaneous], By Application [Vaccine Delivery, Insulin Delivery, Pain Management, Others], By End-user [Hospitals and Clinics, Home Care Settings, Ambulatory Surgical Centers, Others], By Region, Opportunities and Forecast, 2017-2031F
The main purpose of developing needle free injection system was to reduce needlestick injuries, cross-contamination, and needle reuse. Needle free injectors are ideal for personal use to self-administer insulin, hormones, vitamin B-12, and other liquid injectable grade medications.
Home>Industry Reports>Global Needle Free Injection System Market Assessment, Opportunities and Forecast, 2017-2031F
The global needle free injection system market is projected to witness a CAGR of 15.1% during the forecast period 2024-2031, growing from USD 150.86 million in 2023 to USD 464.7 million in 2031. The global needle free injection system is being driven by factors such as the increasing preference of patients towards self-administration, rising hospitalization rates, clinical advantages offered by needle free injection systems as compared to conventional needles, technological advancements, increasing prevalence of chronic diseases, and growing emphasis towards patient safety and comfort. Needle free injectors, also known as jet injectors, are medical devices that deliver medication through the skin by using high pressure stream of fluid without the need for a needle. The main purpose of developing needle free injection system was to reduce needlestick injuries, cross-contamination, and needle reuse. Needle-free injectors have evolved over the years and are being recommended by the World Health Organization to address polio vaccine supply shortages. Needle free injectors are ideal for personal use to self-administer insulin, hormones, vitamin B-12, and other liquid injectable grade medications.
Microneedles are becoming more and more popular because of their ability to enter the human body and skin effectively without causing drug degradation. Their easy-to-operate microscale form factor and painless drug delivery are additional factors driving their demand among the general population.
In June 2023, PharmaJet announced that two new COVID-19 vaccines would only be administered intradermally using its Tropis system. The precision delivery systems developed by PharmaJet, based in Golden, Colorado, solve the problems associated with the delivery of nucleic acid vaccines. The first plasmid DNA COVID-19 vaccine from Zydus Lifesciences can now be delivered using its Tropis system. According to PharmaJet, Tropis has already completed millions of injections as part of several global immunization campaigns. Data consistently showed that nucleic acid vaccines and treatments had higher immunogenicity than those administered by needle and syringe or electroporation.
Increasing Prevalence of Infectious Diseases and Diabetes
The increasing prevalence of diabetes and other infectious diseases is significantly driving the global needle free injection system market. The need for effective and patient-friendly drug or vaccine delivery methods is growing due to the increasing prevalence of diabetes and infectious diseases. By reducing the discomfort associated with infections, needle-free injectors present a convincing alternative that enhances patient adherence to treatment protocols. Needle free injections are becoming more and more popular due to the rise in chronic illnesses like diabetes and autoimmune diseases, which makes needle-free alternatives a painless choice. Additionally, the importance of needle-free technologies and solutions has become more widely recognized due to the increasing risk of transmission through needle-based injections. Since 2021, there has been a significant increase in different infectious diseases, such as TB, influenza, diphtheria, pneumonia, mumps, and malaria, accounting for 20.6%, 354.3%, 220.5%, 2656.1%, and 990.3%, respectively.
Increasing Preference of Patients Towards Self-Administration
Patient preferences for self-administration of medications have significantly changed with the introduction of novel needle-free injection systems. This trend arises from several factors that improve patients' overall wellbeing, safety, and convenience. By eliminating the possibility of needlestick injuries, needle-free injectors reduce the possible risks associated with using traditional needles. By providing painless drug delivery, they improve patient satisfaction and comfort during the administration of medications. Compared to invasive drug delivery systems, needle-free injectors allow for faster drug delivery, which improves bioavailability and efficacy. The need for accessible and user-friendly medication administration methods will grow as the world's population ages and the prevalence of chronic illnesses rises. Needle-free injectors have the potential to completely transform medicine administration, which will ultimately benefit patients and healthcare professionals by providing an effective solution to the problems associated with traditional needle injections.
According to estimates from the Centers for Disease Control and Prevention (CDC), more than 3,85,000 hospital-based workers face needlestick injuries annually. Similar injuries also happen in private homes, clinics, emergency rooms, and other healthcare settings. Sharp injuries have been linked to the transmission of over 20 different pathogens, but they are mainly linked to the transmission of hepatitis B, hepatitis C, and human immunodeficiency virus (HIV).
Technological Advancements
Needle free injectors are a groundbreaking advancement in the field of medical devices and drug/vaccine delivery systems. It offers a patient-friendly and efficient alternative to traditional needle-based injections. The most recent advancement in this field is increasing focus on enhancing dosage control, reducing discomfort, and increasing accuracy. One noteworthy advancement is the use of liquid streams accelerated to high velocities to pierce the skin in place of traditional needles. Personalized healthcare has improved with the advent of smart needle-free injectors that are outfitted with cutting-edge sensors and connectivity features to facilitate real-time monitoring and data collection.
In January 2023, the FDA approved the DropSafe Sicura passive safety needle, an innovative injection needle with a fully passive mechanism that can be used for the intramuscular and subcutaneous injection of vaccines and other drugs, according to a press release from MTD Group's affiliate Pikdare S.p.A. A transparent shield guards the needle and locks automatically after injection, eliminating the need for the healthcare professionals to perform a post-injection incremental activation step.
North America Holds the Largest Share in the Market
North America accounts for more than 50% of the global needle free infection system market. North America’s dominance can be attributed to several factors such as the presence of major players, innovative technologies, and a fast regulatory process by the FDA. The region offers a strong healthcare infrastructure and a high degree of awareness about the advantages of needle-free injection technologies among the public and healthcare professionals. In North America, the prevalence of diabetes and infectious diseases is comparatively high, which generates a significant demand for advanced drug delivery systems. Significant market players have a strong presence in the USA, Canada, Mexico, and global markets. The regulatory framework is favorable, encouraging innovation and the adoption of new medical technologies. The United States has a hassle-free approval and commercialization process for needle-free injection systems due to the FDA's support.
In June 2022, Berkeley-based NovaXS Biotech Corporation, a medical device company, unveiled its smart, needle-free drug delivery device. With its patent-pending Telosis technology, NovaXS will be able to analyze injection data and provide a precise, needle-free medication stream in just 0.3 seconds, enabling more informed health decisions. In a press release, the company stated that its technology is the first of its kind in the world for remote medication delivery and self-administration monitoring, providing a simple and painless substitute.
Fillable Needle Free Injectors Hold the Largest Share Globally
Fillable injectors account for the largest share of the global needle free injection system market. Fillable needle-free injectors offer several advantages over prefilled needle-free injectors. One key advantage is the ability to customize dosages by allowing on-demand filling of the injector device with the desired medication, providing flexibility in drug administration. Fillable injectors also offer the potential for targeted drug delivery, ensuring precise dosages tailored to individual patient needs. Additionally, fillable injectors can accommodate a variety of medications, making them versatile for different treatment regimens. In contrast, prefilled injectors come pre-loaded with a specific dosage, limiting the flexibility in drug administration and customization compared to fillable injectors. Moreover, fillable injectors can be more cost-effective as they allow for the use of generic medications or multiple doses from a single vial, reducing overall treatment costs.
Future Market Scenario (2024-2031F)
The future market scenario for the global needle free injection system market is poised for substantial growth, driven by new technologies. There is an increasing demand for painless drug delivery methods, leading to the adoption of needle-free injectors as a patient-friendly alternative. Advancements in microfluidics and nanotechnology have paved the way for more precise and efficient drug administration. Integration of smart features, such as connectivity with phones and personalized dosing, is becoming a prominent trend. The market is also witnessing the development of wearable injectors that offer convenience and continuous monitoring. Microjet and spring jets are gaining popularity for their effectiveness and reduced discomfort.
Report Scope
“Needle Free Injections System Market Assessment, Opportunities, and Forecast, 2017-2031F”, is a comprehensive report by Markets and Data, providing in-depth analysis and qualitative and quantitative assessment of the current state of the global needle free injections system market, industry dynamics, and challenges. The report includes market size, segmental shares, growth trends, opportunities, and forecast between 2024 and 2031. Additionally, the report profiles the leading players in the industry mentioning their respective market share, business model, competitive intelligence, etc.
|
Report Attribute |
Details |
|
Base Year of the Analysis |
2023 |
|
Historical Period |
2017-2022 |
|
Forecast Period |
2024-2031 |
|
Projected Growth Rate |
CAGR of 15.1% between 2024 and 2031 |
|
Revenue Forecast in 2031 |
USD 464.7 million |
|
Segments Covered |
Products, Technology, Site of Delivery, Application, End-user |
|
Regions Covered |
North America, Europe, South America, Asia-Pacific, Middle East and Africa |
|
Key Companies Profile |
Pharmajet Inc., Crossject SA, Medical International Technology Inc, Micropoint Technologies Pte Ltd, Antres Pharma Inc, Penjet Corporation, NuGen Medical Devices Inc, Ferring International Center SA, Portal Instruments Inc, Bioject Medical Technologies Inc |
|
Customization Scope |
15% free report customization with purchase |
|
Pricing and Purchase Options |
Avail the customized purchase options to fulfill your precise research needs |
|
Delivery Format |
PDF and Excel through email (subject to the license purchased) |
In this report, the global needle free injection system market has been segmented into the following categories:
· By Products
o Fillable
o Prefilled
· By Technology
o Spring Based Needle Free Injectors
o Gas Powered Needle Free Injectors
o Laser Powered Needle Free Injectors
o Vibration Based Needle Free Injectors
· By Site of Delivery
o Intradermal
o Intramuscular
o Subcutaneous
· By Application
o Vaccine Delivery
o Insulin Delivery
o Pain Management
o Others
· By End-user
o Hospitals & Clinics
o Home Care Settings
o Ambulatory Surgical Centers
o Others
· By Region
o North America
o Europe
o Asia-Pacific
o South America
o Middle East and Africa
Key Players Landscape and Outlook
The global needle free injection system market is characterized by a competitive landscape with key players driving innovation and market expansion. The global market is dominated by players such as Pharmajet Inc., Crossject SA, Medical International Technology Inc., Micropoint Technologies Pte Ltd, Antres Pharma Inc., Penjet Corporation, NuGen Medical Devices Inc., Ferring International Center SA, Portal Instruments Inc., and Bioject Medical Technologies Inc. These market players are investing in R&D to improve product efficacy, patient comfort and dosage precision. Partnerships and collaborations between medical device and pharmaceutical companies for the integration of needle free injection systems with specific medications are becoming common, further strengthening the presence of these market players.
In May 2022, the world's first disposable range of needle-free livestock vaccination devices was launched by Pulse NeedleFree Systems, the top provider of needle-free delivery technologies to the animal health sector. As a fixed dose device, the Pulse FX doesn't need to have any parts replaced or maintenance done. Dosage volumes ranging from 0.2 ml to 2.0 ml are available, with options for stationery or hand-held delivery.
Key Players Operating in the Global Needle Free Injection System Market are:
· Pharmajet Inc.
· Crossject SA
· Medical International Technology Inc.
· Micropoint Technologies Pte Ltd
· Antres Pharma Inc.
· Penjet Corporation
· NuGen Medical Devices Inc
· Ferring International Center SA
· Portal Instruments Inc.
· Bioject Medical Technologies Inc.
Markets and Data’s report answers the following questions:
· What is the current and future market size of the product/service in question globally or specific to different countries?
· How are the markets divided into different product/service segments and the market size and growth of each segment?
· What is the market potential of different product segments and their investment case?
· How are the markets predicted to develop in the future and what factors will drive or inhibit growth?
· What is the business environment and regulatory landscape specific to the product/service?
If you can't find what you're searching for or have any custom requirements for the global needle free injection system market, you may approach our team at info@marketsandata.com
Table of Contents
1. Research Methodology
2. Project Scope & Definitions
3. Executive Summary
4. Global Needle Free Injection System Market Outlook, 2017-2031F
4.1. Market Size & Forecast
4.1.1.By Value
4.1.2.By Volume
4.2.2.Prefilled
4.3.1.Spring Based Needle Free Injectors
4.3.2.Gas Powered Needle Free Injectors
4.3.3.Laser Powered Needle Free Injectors
4.3.4.Vibration Based Needle Free Injectors
4.4.1.Intradermal
4.4.2.Intramuscular
4.4.3.Subcutaneous
4.5. By Application
4.5.1.Vaccine Delivery
4.5.2.Insulin Delivery
4.5.3.Pain Management
4.5.4.Others
4.6. By End-user
4.6.1.Hospitals & Clinics
4.6.2.Home Care Settings
4.6.3.Ambulatory Surgical Centers
4.6.4.Others
4.7. By Region
4.7.1. North America
4.7.2. Europe
4.7.3. Asia-Pacific
4.7.4. South America
4.7.5. Middle East and Africa
4.8. By Company Market Share (%), 2023
5. Global Needle Free Injection System Market Outlook, By Region, 2017-2031F
5.1. North America*
5.1.1.Market Size & Forecast
5.1.1.1. By Value
5.1.1.2. By Volume
5.1.2.By Products
5.1.2.1. Fillable
5.1.2.2. Prefilled
5.1.3.By Technology
5.1.3.1. Spring Based Needle Free Injectors
5.1.3.2. Gas Powered Needle Free Injectors
5.1.3.3. Laser Powered Needle Free Injectors
5.1.3.4. Vibration Based Needle Free Injectors
5.1.4.By Site of Delivery
5.1.4.1. Intradermal
5.1.4.2. Intramuscular
5.1.4.3. Subcutaneous
5.1.5.By Application
5.1.5.1. Vaccine Delivery
5.1.5.2. Insulin Delivery
5.1.5.3. Pain Management
5.1.5.4. Others
5.1.6.By End-user
5.1.6.1. Hospitals & Clinics
5.1.6.2. Home Care Settings
5.1.6.3. Ambulatory Surgical Centers
5.1.6.4. Others
5.1.7.United States*
5.1.7.1. Market Size & Forecast
5.1.7.1.1. By Value
5.1.7.1.2. By Volume
5.1.7.2. By Products
5.1.7.2.1. Fillable
5.1.7.2.2. Prefilled
5.1.7.3. By Technology
5.1.7.3.1. Spring Based Needle Free Injectors
5.1.7.3.2. Gas Powered Needle Free Injectors
5.1.7.3.3. Laser Powered Needle Free Injectors
5.1.7.3.4. Vibration Based Needle Free Injectors
5.1.7.4. By Site of Delivery
5.1.7.4.1. Intradermal
5.1.7.4.2. Intramuscular
5.1.7.4.3. Subcutaneous
5.1.7.5. By Application
5.1.7.5.1. Vaccine Delivery
5.1.7.5.2. Insulin Delivery
5.1.7.5.3. Pain Management
5.1.7.5.4. Others
5.1.7.6. By End-user
5.1.7.6.1. Hospitals & Clinics
5.1.7.6.2. Home Care Settings
5.1.7.6.3. Ambulatory Surgical Centers
5.1.7.6.4. Others
5.1.8.Canada
5.1.9.Mexico
*All segments will be provided for all regions and countries covered
5.2. Europe
5.2.1.Germany
5.2.2.France
5.2.3.Italy
5.2.4.United Kingdom
5.2.5.Russia
5.2.6.Netherlands
5.2.7.Spain
5.2.8.Turkey
5.2.9.Poland
5.3. Asia-Pacific
5.3.1.India
5.3.2.China
5.3.3.Japan
5.3.4.Australia
5.3.5.Vietnam
5.3.6.South Korea
5.3.7.Indonesia
5.3.8.Philippines
5.4. South America
5.4.1.Brazil
5.4.2.Argentina
5.5. Middle East & Africa
5.5.1.Saudi Arabia
5.5.2.UAE
5.5.3.South Africa
6. Market Mapping, 2023
6.1. By Products
6.2. By Technology
6.3. By Site of Delivery
6.4. By Application
6.5. By End-user
6.6. By Region
7. Macro Environment and Industry Structure
7.1. Demand Supply Analysis
7.2. Import Export Analysis
7.3. Value Chain Analysis
7.4. PESTEL Analysis
7.4.1.Political Factors
7.4.2.Economic System
7.4.3.Social Implications
7.4.4.Technological Advancements
7.4.5.Environmental Impacts
7.4.6.Legal Compliances and Regulatory Policies (Statutory Bodies Included)
7.5. Porter’s Five Forces Analysis
7.5.1.Supplier Power
7.5.2.Buyer Power
7.5.3.Substitution Threat
7.5.4.Threat from New Entrant
7.5.5.Competitive Rivalry
8. Market Dynamics
8.1. Growth Drivers
8.2. Growth Inhibitors (Challenges and Restraints)
9. Regulatory Framework and Innovation
9.1. Clinical Trials
9.2. Patent Landscape
9.3. Regulatory Approvals
9.4. Innovations/Emerging Technologies
10. Key Players Landscape
10.1. Competition Matrix of Top Five Market Leaders
10.2. Market Revenue Analysis of Top Five Market Leaders (in %, 2023)
10.3. Mergers and Acquisitions/Joint Ventures (If Applicable)
10.4. SWOT Analysis (For Five Market Players)
10.5. Patent Analysis (If Applicable)
11. Pricing Analysis
12. Case Studies
13. Key Players Outlook
13.1. Pharmajet Inc
13.1.1. Company Details
13.1.2. Key Management Personnel
13.1.3. Products & Services
13.1.4. Financials (As reported)
13.1.5. Key Market Focus & Geographical Presence
13.1.6. Recent Developments
13.2. Crossject SA
13.3. Medical International Technology Inc
13.4. Micropoint Technologies Pte Ltd
13.5. Antres Pharma Inc
13.6. Penjet Corporation
13.7. NuGen Medical Devices Inc
13.8. Ferring International Center SA
13.9. Portal Instruments Inc
13.10. Bioject Medical Technologies Inc
*Companies mentioned above DO NOT hold any order as per market share and can be changed as per information available during research work.
14. Strategic Recommendations
About Us & Disclaimer
List of Figures
Figure 1. Global Needle Free Injections System Market, By Value, In USD Million, 2017-2031F
Figure 2. Global Needle Free Injections System Market, By Volume, In Thousand Units, 2017-2031F
Figure 3. Global Needle Free Injections System Market Share (%), By Products, 2017-2031F
Figure 4. Global Needle Free Injections System Market Share (%), By Technology, 2017-2031F
Figure 5. Global Needle Free Injections System Market Share (%), By Site of Delivery, 2017-2031F
Figure 6. Global Needle Free Injections System Market Share (%), By Application, 2017-2031F
Figure 7. Global Needle Free Injections System Market Share (%), By End-user, 2017-2031F
Figure 8. Global Needle Free Injections System Market Share (%), By Region, 2017-2031F
Figure 9. North America Needle Free Injections System Market, By Value, In USD Million, 2017-2031F
Figure 10. North America Needle Free Injections System Market, By Volume, In Thousand Units, 2017-2031F
Figure 11. North America Needle Free Injections System Market Share (%), By Products, 2017-2031F
Figure 12. North America Needle Free Injections System Market Share (%), By Technology, 2017-2031F
Figure 13. North America Needle Free Injections System Market Share (%), By Site of Delivery, 2017-2031F
Figure 14. North America Needle Free Injections System Market Share (%), By Application, 2017-2031F
Figure 15. North America Needle Free Injections System Market Share (%), By End-user, 2017-2031F
Figure 16. North America Needle Free Injections System Market Share (%), By Country, 2017-2031F
Figure 17. United States Needle Free Injections System Market, By Value, In USD Million, 2017-2031F
Figure 18. United States Needle Free Injections System Market, By Volume, In Thousand Units, 2017-2031F
Figure 19. United States Needle Free Injections System Market Share (%), By Products, 2017-2031F
Figure 20. United States Needle Free Injections System Market Share (%), By Technology, 2017-2031F
Figure 21. United States Needle Free Injections System Market Share (%), By Site of Delivery, 2017-2031F
Figure 22. United States Needle Free Injections System Market Share (%), By Application, 2017-2031F
Figure 23. United States Needle Free Injections System Market Share (%), By End-user, 2017-2031F
Figure 24. Canada Needle Free Injections System Market, By Value, In USD Million, 2017-2031F
Figure 25. Canada Needle Free Injections System Market, By Volume, In Thousand Units, 2017-2031F
Figure 26. Canada Needle Free Injections System Market Share (%), By Products, 2017-2031F
Figure 27. Canada Needle Free Injections System Market Share (%), By Technology, 2017-2031F
Figure 28. Canada Needle Free Injections System Market Share (%), By Site of Delivery, 2017-2031F
Figure 29. Canada Needle Free Injections System Market Share (%), By Application, 2017-2031F
Figure 30. Canada Needle Free Injections System Market Share (%), By End-user, 2017-2031F
Figure 31. Mexico Needle Free Injections System Market, By Value, In USD Million, 2017-2031F
Figure 32. Mexico Needle Free Injections System Market, By Volume, In Thousand Units, 2017-2031F
Figure 33. Mexico Needle Free Injections System Market Share (%), By Products, 2017-2031F
Figure 34. Mexico Needle Free Injections System Market Share (%), By Technology, 2017-2031F
Figure 35. Mexico Needle Free Injections System Market Share (%), By Site of Delivery, 2017-2031F
Figure 36. Mexico Needle Free Injections System Market Share (%), By Application, 2017-2031F
Figure 37. Mexico Needle Free Injections System Market Share (%), By End-user, 2017-2031F
Figure 38. Europe Needle Free Injections System Market, By Value, In USD Million, 2017-2031F
Figure 39. Europe Needle Free Injections System Market, By Volume, In Thousand Units, 2017-2031F
Figure 40. Europe Needle Free Injections System Market Share (%), By Products, 2017-2031F
Figure 41. Europe Needle Free Injections System Market Share (%), By Technology, 2017-2031F
Figure 42. Europe Needle Free Injections System Market Share (%), By Site of Delivery, 2017-2031F
Figure 43. Europe Needle Free Injections System Market Share (%), By Application, 2017-2031F
Figure 44. Europe Needle Free Injections System Market Share (%), By End-user, 2017-2031F
Figure 45. Europe Needle Free Injections System Market Share (%), By Country, 2017-2031F
Figure 46. Germany Needle Free Injections System Market, By Value, In USD Million, 2017-2031F
Figure 47. Germany Needle Free Injections System Market, By Volume, In Thousand Units, 2017-2031F
Figure 48. Germany Needle Free Injections System Market Share (%), By Products, 2017-2031F
Figure 49. Germany Needle Free Injections System Market Share (%), By Technology, 2017-2031F
Figure 50. Germany Needle Free Injections System Market Share (%), By Site of Delivery, 2017-2031F
Figure 51. Germany Needle Free Injections System Market Share (%), By Application, 2017-2031F
Figure 52. Germany Needle Free Injections System Market Share (%), By End-user, 2017-2031F
Figure 53. France Needle Free Injections System Market, By Value, In USD Million, 2017-2031F
Figure 54. France Needle Free Injections System Market, By Volume, In Thousand Units, 2017-2031F
Figure 55. France Needle Free Injections System Market Share (%), By Products, 2017-2031F
Figure 56. France Needle Free Injections System Market Share (%), By Technology, 2017-2031F
Figure 57. France Needle Free Injections System Market Share (%), By Site of Delivery, 2017-2031F
Figure 58. France Needle Free Injections System Market Share (%), By Application, 2017-2031F
Figure 59. France Needle Free Injections System Market Share (%), By End-user, 2017-2031F
Figure 60. Italy Needle Free Injections System Market, By Value, In USD Million, 2017-2031F
Figure 61. Italy Needle Free Injections System Market, By Volume, In Thousand Units, 2017-2031F
Figure 62. Italy Needle Free Injections System Market Share (%), By Products, 2017-2031F
Figure 63. Italy Needle Free Injections System Market Share (%), By Technology, 2017-2031F
Figure 64. Italy Needle Free Injections System Market Share (%), By Site of Delivery, 2017-2031F
Figure 65. Italy Needle Free Injections System Market Share (%), By Application, 2017-2031F
Figure 66. Italy Needle Free Injections System Market Share (%), By End-user, 2017-2031F
Figure 67. United Kingdom Needle Free Injections System Market, By Value, In USD Million, 2017-2031F
Figure 68. United Kingdom Needle Free Injections System Market, By Volume, In Thousand Units, 2017-2031F
Figure 69. United Kingdom Needle Free Injections System Market Share (%), By Products, 2017-2031F
Figure 70. United Kingdom Needle Free Injections System Market Share (%), By Technology, 2017-2031F
Figure 71. United Kingdom Needle Free Injections System Market Share (%), By Site of Delivery, 2017-2031F
Figure 72. United Kingdom Needle Free Injections System Market Share (%), By Application, 2017-2031F
Figure 73. United Kingdom Needle Free Injections System Market Share (%), By End-user, 2017-2031F
Figure 74. Russia Needle Free Injections System Market, By Value, In USD Million, 2017-2031F
Figure 75. Russia Needle Free Injections System Market, By Volume, In Thousand Units, 2017-2031F
Figure 76. Russia Needle Free Injections System Market Share (%), By Products, 2017-2031F
Figure 77. Russia Needle Free Injections System Market Share (%), By Technology, 2017-2031F
Figure 78. Russia Needle Free Injections System Market Share (%), By Site of Delivery, 2017-2031F
Figure 79. Russia Needle Free Injections System Market Share (%), By Application, 2017-2031F
Figure 80. Russia Needle Free Injections System Market Share (%), By End-user, 2017-2031F
Figure 81. Netherlands Needle Free Injections System Market, By Value, In USD Million, 2017-2031F
Figure 82. Netherlands Needle Free Injections System Market, By Volume, In Thousand Units, 2017-2031F
Figure 83. Netherlands Needle Free Injections System Market Share (%), By Products, 2017-2031F
Figure 84. Netherlands Needle Free Injections System Market Share (%), By Technology, 2017-2031F
Figure 85. Netherlands Needle Free Injections System Market Share (%), By Site of Delivery, 2017-2031F
Figure 86. Netherlands Needle Free Injections System Market Share (%), By Application, 2017-2031F
Figure 87. Netherlands Needle Free Injections System Market Share (%), By End-user, 2017-2031F
Figure 88. Spain Needle Free Injections System Market, By Value, In USD Million, 2017-2031F
Figure 89. Spain Needle Free Injections System Market, By Volume, In Thousand Units, 2017-2031F
Figure 90. Spain Needle Free Injections System Market Share (%), By Products, 2017-2031F
Figure 91. Spain Needle Free Injections System Market Share (%), By Technology, 2017-2031F
Figure 92. Spain Needle Free Injections System Market Share (%), By Site of Delivery, 2017-2031F
Figure 93. Spain Needle Free Injections System Market Share (%), By Application, 2017-2031F
Figure 94. Spain Needle Free Injections System Market Share (%), By End-user, 2017-2031F
Figure 95. Turkey Needle Free Injections System Market, By Value, In USD Million, 2017-2031F
Figure 96. Turkey Needle Free Injections System Market, By Volume, In Thousand Units, 2017-2031F
Figure 97. Turkey Needle Free Injections System Market Share (%), By Products, 2017-2031F
Figure 98. Turkey Needle Free Injections System Market Share (%), By Technology, 2017-2031F
Figure 99. Turkey Needle Free Injections System Market Share (%), By Site of Delivery, 2017-2031F
Figure 100. Turkey Needle Free Injections System Market Share (%), By Application, 2017-2031F
Figure 101. Turkey Needle Free Injections System Market Share (%), By End-user, 2017-2031F
Figure 102. Poland Needle Free Injections System Market, By Value, In USD Million, 2017-2031F
Figure 103. Poland Needle Free Injections System Market, By Volume, In Thousand Units, 2017-2031F
Figure 104. Poland Needle Free Injections System Market Share (%), By Products, 2017-2031F
Figure 105. Poland Needle Free Injections System Market Share (%), By Technology, 2017-2031F
Figure 106. Poland Needle Free Injections System Market Share (%), By Site of Delivery, 2017-2031F
Figure 107. Poland Needle Free Injections System Market Share (%), By Application, 2017-2031F
Figure 108. Poland Needle Free Injections System Market Share (%), By End-user, 2017-2031F
Figure 109. South America Needle Free Injections System Market, By Value, In USD Million, 2017-2031F
Figure 110. South America Needle Free Injections System Market, By Volume, In Thousand Units, 2017-2031F
Figure 111. South America Needle Free Injections System Market Share (%), By Products, 2017-2031F
Figure 112. South America Needle Free Injections System Market Share (%), By Technology, 2017-2031F
Figure 113. South America Needle Free Injections System Market Share (%), By Site of Delivery, 2017-2031F
Figure 114. South America Needle Free Injections System Market Share (%), By Application, 2017-2031F
Figure 115. South America Needle Free Injections System Market Share (%), By End-user, 2017-2031F
Figure 116. South America Needle Free Injections System Market Share (%), By Country, 2017-2031F
Figure 117. Brazil Needle Free Injections System Market, By Value, In USD Million, 2017-2031F
Figure 118. Brazil Needle Free Injections System Market, By Volume, In Thousand Units, 2017-2031F
Figure 119. Brazil Needle Free Injections System Market Share (%), By Products, 2017-2031F
Figure 120. Brazil Needle Free Injections System Market Share (%), By Technology, 2017-2031F
Figure 121. Brazil Needle Free Injections System Market Share (%), By Site of Delivery, 2017-2031F
Figure 122. Brazil Needle Free Injections System Market Share (%), By Application, 2017-2031F
Figure 123. Brazil Needle Free Injections System Market Share (%), By End-user, 2017-2031F
Figure 124. Argentina Needle Free Injections System Market, By Value, In USD Million, 2017-2031F
Figure 125. Argentina Needle Free Injections System Market, By Volume, In Thousand Units, 2017-2031F
Figure 126. Argentina Needle Free Injections System Market Share (%), By Products, 2017-2031F
Figure 127. Argentina Needle Free Injections System Market Share (%), By Technology, 2017-2031F
Figure 128. Argentina Needle Free Injections System Market Share (%), By Site of Delivery, 2017-2031F
Figure 129. Argentina Needle Free Injections System Market Share (%), By Application, 2017-2031F
Figure 130. Argentina Needle Free Injections System Market Share (%), By End-user, 2017-2031F
Figure 131. Asia-Pacific Needle Free Injections System Market, By Value, In USD Million, 2017-2031F
Figure 132. Asia-Pacific Needle Free Injections System Market, By Volume, In Thousand Units, 2017-2031F
Figure 133. Asia-Pacific Needle Free Injections System Market Share (%), By Products, 2017-2031F
Figure 134. Asia-Pacific Needle Free Injections System Market Share (%), By Technology, 2017-2031F
Figure 135. Asia-Pacific Needle Free Injections System Market Share (%), By Site of Delivery, 2017-2031F
Figure 136. Asia-Pacific Needle Free Injections System Market Share (%), By Application, 2017-2031F
Figure 137. Asia- Pacific Needle Free Injections System Market Share (%), By End-user, 2017-2031F
Figure 138. Asia-Pacific Needle Free Injections System Market Share (%), By Country, 2017-2031F
Figure 139. India Needle Free Injections System Market, By Value, In USD Million, 2017-2031F
Figure 140. India Needle Free Injections System Market, By Volume, In Thousand Units, 2017-2031F
Figure 141. India Needle Free Injections System Market Share (%), By Products, 2017-2031F
Figure 142. India Needle Free Injections System Market Share (%), By Technology, 2017-2031F
Figure 143. India Needle Free Injections System Market Share (%), By Site of Delivery, 2017-2031F
Figure 144. India Needle Free Injections System Market Share (%), By Application, 2017-2031F
Figure 145. India Needle Free Injections System Market Share (%), By End-user, 2017-2031F
Figure 146. China Needle Free Injections System Market, By Value, In USD Million, 2017-2031F
Figure 147. China Needle Free Injections System Market, By Volume, In Thousand Units, 2017-2031F
Figure 148. China Needle Free Injections System Market Share (%), By Products, 2017-2031F
Figure 149. China Needle Free Injections System Market Share (%), By Technology, 2017-2031F
Figure 150. China Needle Free Injections System Market Share (%), By Site of Delivery, 2017-2031F
Figure 151. China Needle Free Injections System Market Share (%), By Application, 2017-2031F
Figure 152. China Needle Free Injections System Market Share (%), By End-user, 2017-2031F
Figure 153. Japan Needle Free Injections System Market, By Value, In USD Million, 2017-2031F
Figure 154. Japan Needle Free Injections System Market, By Volume, In Thousand Units, 2017-2031F
Figure 155. Japan Needle Free Injections System Market Share (%), By Products, 2017-2031F
Figure 156. Japan Needle Free Injections System Market Share (%), By Technology, 2017-2031F
Figure 157. Japan Needle Free Injections System Market Share (%), By Site of Delivery, 2017-2031F
Figure 158. Japan Needle Free Injections System Market Share (%), By Application, 2017-2031F
Figure 159. Japan Needle Free Injections System Market Share (%), By End-user, 2017-2031F
Figure 160. Australia Needle Free Injections System Market, By Value, In USD Million, 2017-2031F
Figure 161. Australia Needle Free Injections System Market, By Volume, In Thousand Units, 2017-2031F
Figure 162. Australia Needle Free Injections System Market Share (%), By Products, 2017-2031F
Figure 163. Australia Needle Free Injections System Market Share (%), By Technology, 2017-2031F
Figure 164. Australia Needle Free Injections System Market Share (%), By Site of Delivery, 2017-2031F
Figure 165. Australia Needle Free Injections System Market Share (%), By Application, 2017-2031F
Figure 166. Australia Needle Free Injections System Market Share (%), By End-user, 2017-2031F
Figure 167. Vietnam Needle Free Injections System Market, By Value, In USD Million, 2017-2031F
Figure 168. Vietnam Needle Free Injections System Market, By Volume, In Thousand Units, 2017-2031F
Figure 169. Vietnam Needle Free Injections System Market Share (%), By Products, 2017-2031F
Figure 170. Vietnam Needle Free Injections System Market Share (%), By Technology, 2017-2031F
Figure 171. Vietnam Needle Free Injections System Market Share (%), By Site of Delivery, 2017-2031F
Figure 172. Vietnam Needle Free Injections System Market Share (%), By Application, 2017-2031F
Figure 173. Vietnam Needle Free Injections System Market Share (%), By End-user, 2017-2031F
Figure 174. South Korea Needle Free Injections System Market, By Value, In USD Million, 2017-2031F
Figure 175. South Korea Needle Free Injections System Market, By Volume, In Thousand Units, 2017-2031F
Figure 176. South Korea Needle Free Injections System Market Share (%), By Products, 2017-2031F
Figure 177. South Korea Needle Free Injections System Market Share (%), By Technology, 2017-2031F
Figure 178. South Korea Needle Free Injections System Market Share (%), By Site of Delivery, 2017-2031F
Figure 179. South Korea Needle Free Injections System Market Share (%), By Application, 2017-2031F
Figure 180. South Korea Needle Free Injections System Market Share (%), By End-user, 2017-2031F
Figure 181. Indonesia Needle Free Injections System Market, By Value, In USD Million, 2017-2031F
Figure 182. Indonesia Needle Free Injections System Market, By Volume, In Thousand Units, 2017-2031F
Figure 183. Indonesia Needle Free Injections System Market Share (%), By Products, 2017-2031F
Figure 184. Indonesia Needle Free Injections System Market Share (%), By Technology, 2017-2031F
Figure 185. Indonesia Needle Free Injections System Market Share (%), By Site of Delivery, 2017-2031F
Figure 186. Indonesia Needle Free Injections System Market Share (%), By Application, 2017-2031F
Figure 187. Indonesia Needle Free Injections System Market Share (%), By End-user, 2017-2031F
Figure 188. Philippines Needle Free Injections System Market, By Value, In USD Million, 2017-2031F
Figure 189. Philippines Needle Free Injections System Market, By Volume, In Thousand Units, 2017-2031F
Figure 190. Philippines Needle Free Injections System Market Share (%), By Products, 2017-2031F
Figure 191. Philippines Needle Free Injections System Market Share (%), By Technology, 2017-2031F
Figure 192. Philippines Needle Free Injections System Market Share (%), By Site of Delivery, 2017-2031F
Figure 193. Philippines Needle Free Injections System Market Share (%), By Application, 2017-2031F
Figure 194. Philippines Needle Free Injections System Market Share (%), By End-user, 2017-2031F
Figure 195. Middle East & Africa Needle Free Injections System Market, By Value, In USD Million, 2017-2031F
Figure 196. Middle East & Africa Needle Free Injections System Market, By Volume, In Thousand Units, 2017-2031F
Figure 197. Middle East & Africa Needle Free Injections System Market Share (%), By Products, 2017-2031F
Figure 198. Middle East & Africa Needle Free Injections System Market Share (%), By Technology, 2017-2031F
Figure 199. Middle East & Africa Needle Free Injections System Market Share (%), By Site of Delivery, 2017-2031F
Figure 200. Middle East & Africa Needle Free Injections System Market Share (%), By Application, 2017-2031F
Figure 201. Middle East & Africa Needle Free Injections System Market Share (%), By End-user, 2017-2031F
Figure 202. Middle East & Africa Needle Free Injections System Market Share (%), By Country, 2017-2031F
Figure 203. Saudi Arabia Needle Free Injections System Market, By Value, In USD Million, 2017-2031F
Figure 204. Saudi Arabia Needle Free Injections System Market, By Volume, In Thousand Units, 2017-2031F
Figure 205. Saudi Arabia Needle Free Injections System Market Share (%), By Products, 2017-2031F
Figure 206. Saudi Arabia Needle Free Injections System Market Share (%), By Technology, 2017-2031F
Figure 207. Saudi Arabia Needle Free Injections System Market Share (%), By Site of Delivery, 2017-2031F
Figure 208. Saudi Arabia Needle Free Injections System Market Share (%), By Application, 2017-2031F
Figure 209. Saudi Arabia Needle Free Injections System Market Share (%), By End-user, 2017-2031F
Figure 210. UAE Needle Free Injections System Market, By Value, In USD Million, 2017-2031F
Figure 211. UAE Needle Free Injections System Market, By Volume, In Thousand Units, 2017-2031F
Figure 212. UAE Needle Free Injections System Market Share (%), By Products, 2017-2031F
Figure 213. UAE Needle Free Injections System Market Share (%), By Technology, 2017-2031F
Figure 214. UAE Needle Free Injections System Market Share (%), By Site of Delivery, 2017-2031F
Figure 215. UAE Needle Free Injections System Market Share (%), By Application, 2017-2031F
Figure 216. UAE Needle Free Injections System Market Share (%), By End-user, 2017-2031F
Figure 217. South Africa Needle Free Injections System Market, By Value, In USD Million, 2017-2031F
Figure 218. South Africa Needle Free Injections System Market, By Volume, In Thousand Units, 2017-2031F
Figure 219. South Africa Needle Free Injections System Market Share (%), By Products, 2017-2031F
Figure 220. South Africa Needle Free Injections System Market Share (%), By Technology, 2017-2031F
Figure 221. South Africa Needle Free Injections System Market Share (%), By Site of Delivery, 2017-2031F
Figure 222. South Africa Needle Free Injections System Market Share (%), By Application, 2017-2031F
Figure 223. South Africa Needle Free Injections System Market Share (%), By End-user, 2017-2031F
Figure 224. By Products Map-Market Size (USD Million) & Growth Rate (%), 2023
Figure 225. By Technology Map-Market Size (USD Million) & Growth Rate (%), 2023
Figure 226. By Site of Delivery Map-Market Size (USD Million) & Growth Rate (%), 2023
Figure 227. By Application Map-Market Size (USD Million) & Growth Rate (%), 2023
Figure 228. By End-user Map-Market Size (USD Million) & Growth Rate (%), 2023
Figure 229. By Region Map-Market Size (USD Million) & Growth Rate (%), 2023
List of Tables
Table 1. Pricing Analysis of Products from Key Players
Table 2. Competition Matrix of Top 5 Market Leaders
Table 3. Mergers & Acquisitions/ Joint Ventures (If Applicable)
Table 4. About Us - Regions and Countries Where We Have Executed Client Projects
Frequently Asked Questions
What are the major drivers influencing the growth of the global needle free injection system market?
Who are the key players operating in the global needle free injection system market?
What are the regions covered in the final report for the global needle free injection system market?
What is the market size and growth rate of the global needle free injection system market?
See Related Reports
UAE Finance Cloud Market Assessment, Opportunities and Forecast, 2017-2031F
UAE finance cloud market is projected to witness a CAGR of 24.22% during the forecast period 2024-2031, growing from USD 681 million in 2023 to USD 3860.82 million in 2031. ....Read More
Published on
September 2024
0
UAE Fintech Market Assessment, Opportunities and Forecast, 2017-2031F
UAE fintech market is projected to witness a CAGR of 15.68% during the forecast period 2024-2031, growing from USD 2.96 billion in 2023 to USD 9.49 billion in 2031.....Read More
Published on
September 2024
3,300
Published on
September 2024
3,300
United States Fish Farming Market Assessment, Opportunities and Forecast, 2017-2031F
United States fish farming market is projected to witness a CAGR of 3.90% during the forecast period 2024-2031, growing from USD 15.93 billion in 2023 to USD 21.64 billion in 2031.....Read More
Published on
September 2024
3,300
Purchase Options
USD ($)
i
2,760
3,000
8%
i
4,050
4,500
10%
i
5,016
5,700
12%
i
6,970
8,200
15%
Tired of Searching?
Looking for Customization?
Some other doubt?
Need insights from a cohort?
REACH US
